[1] 曾绮卿.青少年多囊卵巢综合征的临床、超声和生化特征及其诊断意义[J].基因组学与应用生物学,2020,39(1):435-442. [2] 岳琳,杜丹丽.抗苗勒氏管激素在月经紊乱患者中的临床分析[J].医学理论与实践,2019,32(10):1554-1556. [3] 李茜西,伍萍芝,何琳琳,等.血清维生素D缺乏与多囊卵巢综合征的关联研究[J].中国妇幼保健,2015,30(21):3636-3638. [4] JAFARI-SFIDVAJANI S, AHANGARI R, HOZOORI M, et al. The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial[J]. J Endocrinol Invest, 2018, 41(5):597-607. [5] PEÑA A S, WITCHEL S F, HOEGER K M, et al. Adolescent polycystic ovary syndrome according to the international evidence-based guideline[J]. BMC Med, 2020, 18(1):72. [6] WANG Y, LI H, ZHENG M, et al. Maternal vitamin D deficiency increases the risk of adverse neonatal outcomes in the Chinese population: A prospective cohort study[J]. PLoS One, 2018, 13(4):e0195700. [7] 李琳,杨冬梓.青春期多囊卵巢综合征筛查与管理[J].中国实用妇科与产科杂志,2019,35(3):291-295. [8] SHARAN B, SAGILI H, KAMALANATHAN S K, et al. Serum irisin levels and its association with blood glucose and insulin indices in diagnosing insulin resistance in adolescents with polycystic ovarian syndrome[J]. J Hum Reprod Sci, 2021, 14(2):137-143. [9] 郑波,徐岚,胡泉,等.300例青春期多囊卵巢综合征的高危因素及内分泌代谢特征分析[J].中国计划生育和妇产科,2020,12(11):78-81. [10] 宋玉花,李亚萍.AFC AMH BMP-15 bE_2与bFSH在年轻不孕症女性卵巢低反应与妊娠结局预测中的价值[J].中国妇幼保健,2021,36(8):1826-1829. [11] 张美微,侯丽辉,李妍,等.青春期与育龄期痰湿证多囊卵巢综合征患者的临床特征及代谢差异性研究[J].现代中西医结合杂志,2019,28(2):121-124,148. [12] BAKEER E, RADWAN R, EL MANDOURY A, et al. Anti-Müllerian hormone as a diagnostic marker in Egyptian infertile polycystic ovary syndrome females: correlations with vitamin D, total testosterone, dyslipidemia and anthropometric parameters[J]. J Med Biochem, 2018, 37(4):448-455. [13] WONG H Y Q, LI H W R, LAM K S L, et al. Independent association of serum vitamin D with anti-Mullerian hormone levels in women with polycystic ovary syndrome[J]. Clin Endocrinol (Oxf), 2018, 89(5):634-641. [14] SIMPSON S, SEIFER D B, SHABANOVA V, et al. The association between anti-Müllerian hormone and vitamin 25(OH)D3 serum levels and polycystic ovarian syndrome in adolescent females[J]. Reprod Biol Endocrinol, 2020,18(1):118. [15] MALLOY P J, PENG L, WANG J, et al. Interaction of the vitamin D receptor with a vitamin D response element in the Müllerian-inhibiting substance (MIS) promoter: regulation of MIS expression by calcitriol in prostate cancer cells[J]. Endocrinology, 2009,150(4):1580-1587. [16] SUN H L, LONG S R, FU S X, et al. Association between vitamin D levels and the risk of metabolic syndrome in a rural Chinese population[J]. Biomed Environ Sci, 2021, 34(4):330-333. [17] PARK C Y, SHIN Y, KIM J H,et al. Effects of high fat diet-induced obesity on vitamin D metabolism and tissue distribution in vitamin D deficient or supplemented mice[J]. Nutr Metab (Lond), 2020, 17:44. [18] ZAKHAROVA I, KLIMOV L, KURYANINOVA V, et al. Vitamin D insufficiency in overweight and obese children and adolescents[J]. Front Endocrinol (Lausanne), 2019, 10:103. [19] DENNIS N A, HOUGHTON L A, PANKHURST M W, et al. Acute supplementation with high dose vitamin D3 increases serum anti-Müllerian hormone in young women[J]. Nutrients, 2017, 9(7):719. |